Ashvattha Therapeutics
Redwood City, US · Founded 2015 · California corporation · 1 known investors
Founders & leadership
Ashvattha Therapeutics was founded in 2015 by Jeffrey Cleland, Kannan Rangaramanujam, and Sujatha Kannan.
JC
Jeffrey ClelandManager of Company
KR
Kannan RangaramanujamManager of Company
SK
Sujatha KannanManager of Company
Board
JH
Investors · 1
Reported raises · per SEC filings
Form D private placements$61.4M disclosed across 6 rounds · 2016–2021
▶$60.2MraisedDec 2022 · 107 investors · BiotechnologyRule 506(b)
▶$60.2MraisedDec 2022 · 107 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Yuhang ZhaoDirector
- Jeffrey ClelandExecutive Officer, Director
- George MontgomeryDirector
- Jay ZaveriDirector
- Amount sold
- $60.2M
- Sales commissions
- $1.4M
- Placement agents
- GP Numenkari Inc.
- First sale
- Apr 2021
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$250KraisedMay 2019 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedMay 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey ClelandExecutive Officer, Director
- Jay ZaveriDirector
- Sujatha KannanExecutive Officer, Director
- Barbara SlusherDirector
- Kannan RangaramanujamExecutive Officer, Director
- Offering amount
- $6.4M
- Amount sold
- $250K
- First sale
- May 2019
- Incorporated
- Limited Liability Company, California, 2015
- Federal exemptions
- 06b
▶$200KraisedJan 2019 · 1 investors · BiotechnologyRule 506(b)
▶$200KraisedJan 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Barbara SlusherDirector
- Sujatha KannanExecutive Officer, Director
- Jeffrey ClelandExecutive Officer, Director
- Kannan RangaramanujamExecutive Officer, Director
- Offering amount
- $200K
- Amount sold
- $200K
- First sale
- Dec 2018
- Incorporated
- Limited Liability Company, California, 2015
- Federal exemptions
- 06b
▶$400KraisedJun 2018 · 1 investors · BiotechnologyRule 506(b)
▶$400KraisedJun 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey ClelandExecutive Officer
- Sujatha KannanExecutive Officer
- Kannan RangaramanujamExecutive Officer
- Offering amount
- $400K
- Amount sold
- $400K
- First sale
- May 2018
- Incorporated
- Limited Liability Company, California, 2015
- Federal exemptions
- 06b
▶$37.4KraisedJun 2016 · 1 investors · BiotechnologyRule 506(b)
▶$37.4KraisedJun 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sujatha KannanExecutive Officer
- Jeffrey ClelandExecutive Officer
- Kannan RangaramanujamExecutive Officer
- Justin HanesExecutive Officer
- Offering amount
- $37.4K
- Amount sold
- $37.4K
- First sale
- May 2016
- Incorporated
- Limited Liability Company, California, 2015
- Federal exemptions
- 06b
▶$300KraisedMar 2016 · 4 investors · BiotechnologyRule 506(b)
▶$300KraisedMar 2016 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey ClelandExecutive Officer
- Kannan RangaramanujamExecutive Officer
- Justin HanesExecutive Officer
- Sujatha KannanExecutive Officer
- Offering amount
- $700K
- Amount sold
- $300K
- First sale
- Feb 2016
- Incorporated
- Limited Liability Company, California, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Ashvattha Therapeutics?
- Ashvattha Therapeutics was founded by Jeffrey Cleland, Kannan Rangaramanujam, Sujatha Kannan in 2015.
- Who are Ashvattha Therapeutics's investors?
- Ashvattha Therapeutics's investors include Catalio Capital Management, LP.
- How much funding has Ashvattha Therapeutics raised?
- Ashvattha Therapeutics has disclosed $61.4M raised across 6 rounds.
- Where is Ashvattha Therapeutics headquartered?
- Ashvattha Therapeutics is headquartered in Redwood City, US.